BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 3897618)

  • 1. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoembryonic antigen (CEA) levels of peripheral and portal blood and tumor histopathology in colorectal cancer].
    Tabuchi Y; Deguchi H; Imanishi K; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1986 Dec; 87(12):1540-7. PubMed ID: 3807878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
    Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
    Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukocyte migration test and determination of carcinoembryonic antigens in the postoperative follow-up care of colon and rectum carcinoma].
    Schulz U; Zoeller M; Matzku S
    Chir Forum Exp Klin Forsch; 1978; (1978):221-5. PubMed ID: 752590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
    Quentmeier A; Schlag P; Herfarth C
    Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA levels at recurrence and metastases; importance for detecting secondary disease.
    Rieger A; Wahren B
    Scand J Gastroenterol; 1975; 10(8):869-74. PubMed ID: 1202621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in patients following clinically curative resection of colorectal cancer.
    Steele G; Sonis S; Stelos P; Rittgers R; Zamcheck N; Finn D; Maltz J; Mayer R; Lokich J; Wilson RE
    Surgery; 1978 Jun; 83(6):648-54. PubMed ID: 205963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum.
    Cohen AM; Wood WC
    Surg Gynecol Obstet; 1979 Jul; 149(1):22-6. PubMed ID: 451823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Portal blood level of carcinoembryonic antigen (CEA) in colorectal cancer: correlation between tumor CEA content and immunohistochemical staining].
    Shimoyama T; Fukuda Y; Kusano H; Shimizu T; Takahira R; Itoh S; Watabe S; Miyashita K; Ishikawa H; Nakagoe T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2245-50. PubMed ID: 2457355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CEA determination in the follow-up of colorectal cancers].
    Lauterbach M; Dehne A; Hesse V; Höfig G
    Zentralbl Chir; 1987; 112(15):968-74. PubMed ID: 3673304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the role of CEA-monotoring in the diagnosis of colorectal carcinomas and recidivations (author's transl)].
    Anders A; Kruppa P
    Zentralbl Chir; 1980; 105(20):1342-52. PubMed ID: 7210975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
    Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
    Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.